4 free views remaining today

developmental and epileptic encephalopathy 38

Description

Developmental and Epileptic Encephalopathy (DEE)

Developmental and epileptic encephalopathy (DEE) is a severe group of epilepsies characterized by seizures and frequent epileptiform activity. It is a heterogeneous group of disorders that affect early brain development, leading to significant cognitive and motor impairments.

Key Features:

  • Seizures: DEEs are marked by recurrent seizures, which can be focal or generalized.
  • Epileptiform Activity: Frequent epileptiform discharges on EEG are a hallmark of DEEs.
  • Developmental Delay: Cognitive and motor development is impaired in individuals with DEEs.

Types of DEEs:

  • Infantile Spasms (DEE1): A type of seizure disorder characterized by infantile spasms, which can be associated with developmental delay.
  • Other forms of DEEs: Various other subtypes of DEEs have been described, each with distinct clinical features.

Impact on Development:

  • Cognitive Impairment: Individuals with DEEs often experience significant cognitive impairments, including intellectual disability.
  • Motor Delay: Motor development is also impaired in individuals with DEEs.

References:

  • [2] Developmental and epileptic encephalopathies, the most severe group of epilepsies, are characterized by seizures and frequent epileptiform activity.
  • [3] Developmental and epileptic encephalopathy (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity.
  • [7] Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities.

Additional Characteristics

  • Seizures
  • Cognitive Impairment
  • Developmental Delay
  • Motor Delay
  • Epileptiform Activity

Signs and Symptoms

Developmental and Epileptic Encephalopathy Signs and Symptoms

Developmental and epileptic encephalopathy (DEE) is a complex condition characterized by severe cognitive, behavioral, and motor impairments. The signs and symptoms of DEE can vary widely among individuals but often include:

  • Severe developmental delay: Most infants with DEE show severely impaired global development, including delayed or absent milestones in physical, language, and cognitive development [4].
  • Hypotonia and poor head control: Infants with DEE may exhibit hypotonia (low muscle tone) and poor head control, which can lead to difficulties with sitting, crawling, and walking [4].
  • Visual disturbances: Visual impairments, including cortical blindness, are common in individuals with DEE [3].
  • Abnormal movements: Spasticity, chorea, generalized dystonia, quadriplegic dyskinesia, recurrent status dystonicus, and other abnormal movements can occur in people with DEE [8].
  • Intellectual disability: Intellectual disability is often severe to profound in individuals with STXBP1 encephalopathy, a subtype of DEE [9].
  • Seizures: Epileptiform activity is a hallmark feature of DEE, and seizures can be frequent and difficult to control [5].

These signs and symptoms can vary widely among individuals with DEE, and the condition often requires comprehensive diagnostic evaluation and management by a multidisciplinary team.

Additional Symptoms

  • Visual disturbances
  • Seizures
  • Intellectual disability
  • Abnormal movements
  • Severe developmental delay
  • Hypotonia and poor head control

Diagnostic Tests

Diagnostic Tests for Developmental and Epileptic Encephalopathy (DEE)

Developmental and Epileptic Encephalopathy (DEE) is a complex condition that requires comprehensive diagnostic testing to determine its underlying causes. The following tests are commonly used to diagnose DEE:

  • Electroencephalogram (EEG): An EEG is typically the first test ordered to evaluate the electrical activity of the brain in children with DEEs. The EEGs in these children are usually very abnormal, showing diffuse slowing of the background and frequent seizure discharges [4].
  • Magnetic Resonance Imaging (MRI): MRI scans can help identify any structural abnormalities in the brain that may be contributing to the condition.
  • Genetic testing: Genetic testing via blood, saliva samples or a skin biopsy can help identify genetic mutations that may be causing DEE. Clinical testing using extensive gene panels, exomes, and genomes is currently accessible and has resulted in higher rates of diagnosis and management [2].
  • Sleep and wake electroencephalogram (EEG) and/or Video EEG: These tests can provide more detailed information about the brain's electrical activity during sleep and wakefulness.
  • Molecular testing: Molecular testing can facilitate the diagnosis of the aetiology of the DEE by identifying specific genetic mutations [9].

In some cases, additional tests may be considered to rule out other conditions that may be causing similar symptoms. These include:

  • Next-generation sequencing (NGS): NGS is a technique used to analyze large amounts of DNA data and can help identify genetic mutations that may be contributing to DEE.
  • Other diagnostic tests: Other diagnostic tests, such as blood tests or imaging studies, may also be ordered to rule out other conditions.

It's worth noting that the diagnosis of DEE often requires a comprehensive evaluation by a multidisciplinary team of healthcare professionals, including neurologists, geneticists, and other specialists.

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Genetic testing
  • Next-generation sequencing (NGS)
  • Electroencephalogram (EEG)
  • Molecular testing
  • or Video EEG

Treatment

Treatment Options for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.

  • Medications: Anticonvulsant medications are the first line of treatment for DEEs. However, response to medication can be poor, and seizures may be difficult to control [1]. In some cases, multiple anticonvulsants may be used in combination to achieve better seizure control [2].
  • Surgical Options: In rare cases, surgical interventions such as corpus callosotomy or hemispherectomy may be considered for patients with DEEs who have severe and uncontrolled seizures [3].
  • Vagus Nerve Stimulation (VNS): VNS is a device that is implanted under the skin to stimulate the vagus nerve, which can help reduce seizure frequency. While VNS has been shown to be effective in some cases of DEEs, its use is still limited and requires further research [4].
  • Dietary Therapies: Some patients with DEEs may benefit from dietary therapies such as the ketogenic diet or modified Atkins diet, which can help reduce seizure frequency by altering metabolism [5].

It's essential to note that each patient with DEEs is unique, and treatment plans should be tailored to individual needs. A multidisciplinary team of healthcare professionals, including neurologists, epileptologists, and other specialists, should work together to develop a comprehensive treatment plan.

References:

[1] May 23, 2022 — Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which are often drug-resistant...

[2] by CJ Landmark · 2021 · Cited by 41 — Developmental and epileptic encephalopathies (DEEs) are among the most challenging of all epilepsies to manage, given the exceedingly...

[3] by C Johannessen Landmark · 2021 · Cited by 41 — Developmental and epileptic encephalopathies (DEEs) are among the most challenging of all epilepsies to manage, given the exceedingly...

[4] by I Bertocchi · 2023 · Cited by 11 — Developmental and epileptic encephalopathies are childhood syndromes of severe epilepsy associated with cognitive and behavioral disorders.

[5] Epileptic encephalopathies are an epileptic condition characterized by early-onset seizures. Learn everything you need to know at CHOC.org.

Recommended Medications

  • Medications
  • Vagus Nerve Stimulation (VNS)
  • Dietary Therapies
  • Surgical Options

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a complex condition that requires accurate diagnosis to determine the underlying cause. The differential diagnoses for DEE include:

  • Early Myoclonic Encephalopathy: This is a rare and severe form of epilepsy that affects infants and young children, characterized by sudden muscle contractions and developmental delays [1].
  • West Syndrome: Also known as infantile spasms, this condition is marked by clusters of seizures in infants, often accompanied by developmental regression and intellectual disability [7].
  • Other Early-Onset Epileptic Encephalopathies: These include conditions such as Othahara syndrome, early myoclonic encephalopathy, and others that share similar characteristics with DEE [7].

Key Considerations for Diagnosis

When diagnosing DEE, it is essential to consider the following factors:

  • EEG Results: Electroencephalograms (EEGs) are crucial in identifying abnormal brain activity patterns associated with DEE [2].
  • Developmental Impairment: Assessing developmental delays or intellectual disability is vital in determining the presence of DEE [3].
  • Genetic Factors: Genetic testing may be necessary to identify underlying genetic mutations that contribute to DEE [4].

References

[1] Context 1: Abnormal Neonatal EEG [2] Context 2: The electroencephalographs (EEGs) in children with DEEs are typically very abnormal, showing diffuse slowing of the background, and frequent seizure discharges. [3] Context 3: GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected ... [4] Context 9: An underlying etiology drives developmental outcomes directly (developmental encephalopathy) and also results in epilepsy.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2786
owl#annotatedSource
t353386
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080417
core#notation
DOID:0080417
oboInOwl#hasDbXref
MIM:617020
oboInOwl#hasExactSynonym
early infantile epileptic encephalopathy 38
rdf-schema#label
developmental and epileptic encephalopathy 38
IAO_0000115
A developmental and epileptic encephalopathy characterized by onset of seizures between 4 and 7 months of age, severely impaired global development, hypotonia with poor head control, and visual inattention that has_material_basis_in homozygous or compound heterozygous mutation in the ARV1 gene on chromosome 1q42.
rdf-schema#subClassOf
t353786
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.